Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

tive expense was $12.4 million in the third quarter of 2011 as compared to $10.2 million in the third quarter of 2010.  

Net loss for the third quarter ended September 30, 2011 was $24.1 million or $0.21 loss per share.

The company also announced upcoming presentations at medical meetings and scientific congresses scheduled for the fourth quarter of 2011:

Chemotherapy Foundation Symposium XXIX: Innovative Cancer Therapy for Tomorrow, New York, NY:

  • Session Title: "Evaluating Single-Agent NKTR-102 in Metastatic Breast Cancer"
  • Presenter: Edith Perez, MD
  • Session Type: Oral
  • Program Track: Breast Cancer
  • Date and Time: November 10, 2011, 1:25 PM Eastern Time

  • Neuroscience 2011: Society for Neuroscience Annual Meeting, Washington, DC:Preclinical data for NKTR-192, a new opioid drug candidate being developed to treat acute pain, will be presented.

  • Abstract Title: "Pharmacological characterization of an orally active opioid analgesic with rapid onset of activity and low abuse liability." Harrison, S., et al.  
  • Abstract/Poster Number: #178.10/NN20
  • Session Title/Track:  "Pharmacology Relevant to Pain, Addiction, and Development"
  • Date and Time: Nov 13, 2011, 8:00 AM - 12:00 PM Eastern Time

  • 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, San Francisco, CAPreclinical data for NKTR-102 in ovarian cancer will be presented.

  • Abstract Title: "Strong synergistic activity of NKTR-102 - pegylated liposomal doxorubicin (PLD) combination therapy in a nonclinical model of platinum-resistant A2780 human ovarian cancer." Hoch, et al.
  • Abstract/Poster Number: C209
  • Session Title/Track:  Topoisomerase Inhibitors
  • Date and Time: Nov 15, 2011, 12:30 PM - 2:30 PM Pacific Time

  • Conference Call to Discuss Third Quarter 2011 Financial
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
    2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
    3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
    4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
    5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
    6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
    7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
    8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
    9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
    10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
    11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) ... agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL ... secured debt financing. CareView is an information technology provider ... Under the credit agreement, PDL will provide ... in two tranches of $20 million, based upon the ...
    (Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
    (Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
    Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
    ... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
    ... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
    Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
    (Date:6/30/2015)... ... 2015 , ... When it comes to volunteering abroad, not many people end ... be too high. However, there are affordable programs to be had such as those ... cost. One such volunteer named Uzma Aishah, a student at the International Medical University ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe Plumbing, Inc. ... San Diego. Bill Howe offers all employees ample opportunity for education and training ... notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego ...
    (Date:6/30/2015)... , ... June 30, 2015 , ... ... June 24, 2015 amidst bright skies and inspirational words. , The independent, ... processional walk from the Glenholme building to the school’s Center for the Arts. ...
    (Date:6/30/2015)... ... 2015 , ... Lecrae is quickly developing into one of the biggest music ... New York Times to Billboard Magazine and Variety, among others. His transparency and ... why so many people are taking notice. , “We are very excited about this ...
    (Date:6/30/2015)... Church, VA (PRWEB) , ... June 30, 2015 ... ... 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado Springs ... of continuing nursing education and networking. Each year, this premiere event for psychiatric-mental ...
    Breaking Medicine News(10 mins):Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3
    ... boosted hearing in such children , THURSDAY, Feb. ... hearing improvement for children and teens with single-sided deafness, ... 3 percent of children have deafness on one side, ... difficulties and behavioral problems. Traditional external hearing aids are ...
    ... ... NFL Draft pick would have to find a personal trainer, physical therapist, ... them compete with the best athletes in the world. But Athletes, ... offered an NFL Combine preparation program, and this year Trigger Point Performance ...
    ... , Scientists at the Johns Hopkins Kimmel Cancer Center ... cancer patients to develop individualized blood tests they believe ... blood tests, believed to be the first of their ... therapy and determine cancer recurrence., "We believe this ...
    ... It is not unusual to hear people blame their metabolism ... process that shapes how our bodies turn food into energy -- ... fit into your favorite jeans. In fact, differences in ... cells, though the mechanism behind it is unclear. Now new research ...
    ... patients perform significantly better on tests of cognitive function than ... MRI scans of the patients showed that the fitter MS ... show deterioration as a result of MS, as well as ... that aerobic fitness has a protective effect on parts of ...
    ... ... Opinion Survey and Special Supplement on Health Care Reform , ... Indianapolis, IN (Vocus) February 18, 2010 -- ... benefits advisory organizations, today announced the opening of the 2010 UBA Employer Opinion ...
    Cached Medicine News:Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 2Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 3Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 2Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 3Health News:Chemical tags likely to affect metabolism, cancer development 2Health News:Exercise helps protect brain of multiple sclerosis patients 2Health News:Exercise helps protect brain of multiple sclerosis patients 3Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 2Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 3
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    ... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
    ... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    Medicine Products: